| 000 | 01545 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516211126.0 | ||
| 264 | 0 | _c20141112 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.12498 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaker, D J | |
| 245 | 0 | 0 |
_aCharacterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cApr 2014 |
||
| 300 |
_a1629-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aEnzyme Activators _xadministration & dosage |
| 650 | 0 | 4 |
_aGlucokinase _xdeficiency |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTranslational Research, Biomedical _xmethods |
| 700 | 1 | _aAtkinson, A M | |
| 700 | 1 | _aWilkinson, G P | |
| 700 | 1 | _aCoope, G J | |
| 700 | 1 | _aCharles, A D | |
| 700 | 1 | _aLeighton, B | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 171 _gno. 7 _gp. 1629-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.12498 _zAvailable from publisher's website |
| 999 |
_c23774986 _d23774986 |
||